Youji Feng

683 total citations
33 papers, 582 citations indexed

About

Youji Feng is a scholar working on Molecular Biology, Reproductive Medicine and Cancer Research. According to data from OpenAlex, Youji Feng has authored 33 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 12 papers in Reproductive Medicine and 10 papers in Cancer Research. Recurrent topics in Youji Feng's work include Ovarian cancer diagnosis and treatment (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Cells and Metastasis (4 papers). Youji Feng is often cited by papers focused on Ovarian cancer diagnosis and treatment (11 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cancer Cells and Metastasis (4 papers). Youji Feng collaborates with scholars based in China and United States. Youji Feng's co-authors include Hongyan Jin, Luoqi Jia, Yunyan Sun, Tao Zhang, Binhua P. Zhou, Yadi Wu, Yinhua Yu, Jiayi Zhou, Suqing Liu and Zhenbo Zhang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Endocrinology.

In The Last Decade

Youji Feng

33 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Youji Feng China 12 350 187 129 107 80 33 582
Maxwell N. Skor United States 8 237 0.7× 159 0.9× 68 0.5× 33 0.3× 164 2.0× 14 488
Aurélia E. Lewis Norway 15 428 1.2× 90 0.5× 59 0.5× 52 0.5× 159 2.0× 27 598
M L Moyer United States 9 366 1.0× 129 0.7× 82 0.6× 70 0.7× 366 4.6× 11 715
Allen Schroering United States 13 399 1.1× 110 0.6× 95 0.7× 53 0.5× 19 0.2× 18 654
Caroline A. Lamb Argentina 17 385 1.1× 388 2.1× 170 1.3× 40 0.4× 322 4.0× 44 790
Kristofer C. Berrett United States 9 287 0.8× 87 0.5× 89 0.7× 25 0.2× 86 1.1× 13 447
Wen-Shu Sun Japan 12 128 0.4× 77 0.4× 36 0.3× 90 0.8× 106 1.3× 17 419
Xia Qiu China 16 321 0.9× 158 0.8× 176 1.4× 65 0.6× 29 0.4× 26 565
Takao Matsuda Japan 17 539 1.5× 136 0.7× 186 1.4× 27 0.3× 180 2.3× 38 884
Heather N. Andrews Canada 8 250 0.7× 150 0.8× 80 0.6× 15 0.1× 108 1.4× 14 404

Countries citing papers authored by Youji Feng

Since Specialization
Citations

This map shows the geographic impact of Youji Feng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Youji Feng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Youji Feng more than expected).

Fields of papers citing papers by Youji Feng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Youji Feng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Youji Feng. The network helps show where Youji Feng may publish in the future.

Co-authorship network of co-authors of Youji Feng

This figure shows the co-authorship network connecting the top 25 collaborators of Youji Feng. A scholar is included among the top collaborators of Youji Feng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Youji Feng. Youji Feng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Suqing, Jing Ping Sun, Bin Cai, et al.. (2016). NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer. Tumor Biology. 37(7). 9671–9680. 66 indexed citations
2.
Qin, Yan, Fangyuan Wang, Yi Miao, et al.. (2016). Sex-determining region Y-box3 (SOX3) functions as an oncogene in promoting epithelial ovarian cancer by targeting Src kinase. Tumor Biology. 37(9). 12263–12271. 16 indexed citations
3.
Zhang, Yingli, Youji Feng, Lü Chen, & Jianqing Zhu. (2015). Effects of Intermediate-Conductance Ca2+-Activated K+ Channels on Human Endometrial Carcinoma Cells. Cell Biochemistry and Biophysics. 72(2). 515–525. 16 indexed citations
4.
Liu, Yingtao, Xiang Tao, Luoqi Jia, et al.. (2012). Knockdown of RAB25 promotes autophagy and inhibits cell growth in ovarian cancer cells. Molecular Medicine Reports. 6(5). 1006–1012. 34 indexed citations
5.
Tao, Xiang, Hongyan Jin, Robert C. Bast, et al.. (2011). Abstract 4540: Follicle-stimulating hormone (FSH) enhances the proliferation of epithelial ovarian cancer cells by activating transient receptor potential channel C3 (TRPC3). Cancer Research. 71(8_Supplement). 4540–4540. 1 indexed citations
6.
Sun, Yunyan, Lu Meng, Xiaowei Xi, et al.. (2011). Regulation of Epithelial-Mesenchymal Transition by Homeobox Gene DLX4 in JEG-3 Trophoblast Cells: A Role in Preeclampsia. Reproductive Sciences. 18(11). 1138–1145. 27 indexed citations
7.
Feng, Youji. (2011). Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells. Oncology Reports. 26(6). 1497–503. 12 indexed citations
8.
Jin, Hongyan, Yinhua Yu, Tao Zhang, et al.. (2009). Snail is critical for tumor growth and metastasis of ovarian carcinoma. International Journal of Cancer. 126(9). 2102–2111. 133 indexed citations
9.
Yao, Liangqing, et al.. (2007). Characteristics and differentiated mechanism of vascular endothelial cells-like derived from epithelial ovarian cancer cells induced by hypoxia. International Journal of Oncology. 30(5). 1069–75. 9 indexed citations
10.
Yi, Xiaofang, Shiming Fan, Ming Yao, & Youji Feng. (2006). Comparison of efficacy and toxicity profile between intraperitoneal and intravenous topotecan in human ovarian cancer xenografts.. PubMed. 38(1). 88–91. 1 indexed citations
11.
Ding, Jingxin, Youji Feng, Liangqing Yao, et al.. (2006). The reinforcement of invasion in epithelial ovarian cancer cells by 17β-Estradiol is associated with up-regulation of Snail. Gynecologic Oncology. 103(2). 623–630. 43 indexed citations
12.
Shen, Keng, Youji Feng, Ding Ma, et al.. (2005). [A multicenter randomized clinical trial of weekly paclitaxel and carboplatin vs three weeks paclitaxel and carboplatin as first line chemotherapy in epithelial ovarian cancer].. PubMed. 85(30). 2099–103. 5 indexed citations
13.
Zhou, Li, et al.. (2005). [Antitumor effect of endothelial progenitor cells with TRAIL gene transfection on ovarian carcinoma xenografts in nude mice].. PubMed. 24(11). 1312–6. 1 indexed citations
14.
Jiang, Hongyuan & Youji Feng. (2004). [Inhibition of hypoxia-inducible factor 1alpha expression and tumor growth in SKOV3 ovarian cancer model by sirolimus].. PubMed. 39(7). 474–7. 4 indexed citations
15.
Feng, Youji. (2003). Effect of Progesterone Combined with Chemotherapy on Epithelial Ovarian Cancer. 6 indexed citations
16.
Chen, Xiaojun & Youji Feng. (2003). Effect of progesterone combined with chemotherapy on epithelial ovarian cancer.. PubMed. 116(3). 388–91. 7 indexed citations
17.
Feng, Youji, et al.. (2003). [Clinical features and prognostic factors of malignant ovarian teratoma].. PubMed. 25(4). 427–30. 1 indexed citations
18.
Chen, Jianli, Youji Feng, & Qin Zhang. (2002). Multicellular-mediated resistance to cisplatin and taxol in human ovarian cancer SK-OV-3IP1 multicellular aggregates. Chinese Journal of Cancer Research. 14(3). 165–169. 1 indexed citations
19.
Chen, Jianli, Youji Feng, & Qin Zhang. (2001). Multicellular-mediated expression of P-GP and MRP and relationship with cell cycle profiles in human ovarian cancer SK-OV-3ip1 multicellular aggregates. Chinese Journal of Cancer Research. 13(4). 258–261. 1 indexed citations
20.
Feng, Youji, Linna Xia, Jean Rivier, et al.. (1991). An Inhibitory Effect of Interleukin-la on Basal Gonadotropin Release in the Ovariectomized Rhesus Monkey: Reversal by a Corticotropin-Releasing Factor Antagonist*. Endocrinology. 128(4). 2077–2082. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026